2 recruiting. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Recruiting 2 |
Follow Kyungsub Song: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| STEPwise De-escalation and Optimizing Withdrawal of ARNI and SGLT2i in Normalized Heart Failure Stepwise Withdrawal of ARNI and SGLT2i, Continued Guideline-Directed Medical Therapy - Heart Failure With Reduced Ejection Fraction, Heart Failure | Phase 4 | Recruiting | Kyungsub Song | 80 | 2026-08-12 | 2026-09-02 |
| Delayed Initiation of ARNI and SGLT2i in Heart Failure With Corrected Aetiology (DELAY-HF), Pilot Study Sacubitril / Valsartan, SGLT-2 inhibitor, SGLT2 Inhibition - Heart Failure Due to Coronary Artery Disease, Valvular Cardiomyopathy | Phase 4 | Recruiting | Kyungsub Song | 80 | 2026-05-20 | 2026-09-02 |
Heart Failure (2) · Heart Valve Diseases (2) · Ventricular Dysfunction, Left (1)
Sodium-Glucose Transporter 2 Inhibitors (1) · sacubitril and valsartan sodium hydrate drug combination (1)
South Korea (2)
Hyung Gon Je, Professor (1) · Jun Ho Lee, Professor (1) · Su Jin Park, Professor (1) · Younju Rhee, Professor (1)